BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15997177)

  • 1. [Molecular pathogenesis of Wiskott-Aldrich syndrome].
    Sasahara Y; Tsuchiya S
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):140-7. PubMed ID: 15997177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
    Sasahara Y
    Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wiskott-Aldrich syndrome.
    Orange JS; Stone KD; Turvey SE; Krzewski K
    Cell Mol Life Sci; 2004 Sep; 61(18):2361-85. PubMed ID: 15378206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
    Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
    J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
    Imai K; Nonoyama S; Ochs HD
    Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
    Snapper SB; Rosen FS
    Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wiskott-Aldrich Syndrome causing mutation, Pro373Ser restricts conformational changes essential for WASP activity in T-cells.
    Jain N; George B; Thanabalu T
    Biochim Biophys Acta; 2014 Apr; 1842(4):623-34. PubMed ID: 24440360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.
    Stewart DM; Tian L; Nelson DL
    J Immunol; 1999 Apr; 162(8):5019-24. PubMed ID: 10202051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of WASp in T cells and B cells.
    Sun X; Wei Y; Lee PP; Ren B; Liu C
    Cell Immunol; 2019 Jul; 341():103919. PubMed ID: 31047647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel mutations of Wiskott-Aldrich syndrome: the molecular prediction of interaction between the mutated WASP L101P with WASP-interacting protein by molecular modeling.
    Kim MK; Kim ES; Kim DS; Choi IH; Moon T; Yoon CN; Shin JS
    Biochim Biophys Acta; 2004 Oct; 1690(2):134-40. PubMed ID: 15469902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses.
    Orange JS; Ramesh N; Remold-O'Donnell E; Sasahara Y; Koopman L; Byrne M; Bonilla FA; Rosen FS; Geha RS; Strominger JL
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11351-6. PubMed ID: 12177428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.
    Notarangelo LD; Ochs HD
    Curr Opin Immunol; 2003 Oct; 15(5):585-91. PubMed ID: 14499269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement.
    Huang W; Ochs HD; Dupont B; Vyas YM
    J Immunol; 2005 Mar; 174(5):2602-11. PubMed ID: 15728466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the molecular basis of Wiskott-Aldrich syndrome.
    Abo A
    Cell Mol Life Sci; 1998 Oct; 54(10):1145-53. PubMed ID: 9817992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells.
    Ramesh N; Antón IM; Hartwig JH; Geha RS
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14671-6. PubMed ID: 9405671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WIP remodeling actin behind the scenes: how WIP reshapes immune and other functions.
    Noy E; Fried S; Matalon O; Barda-Saad M
    Int J Mol Sci; 2012; 13(6):7629-7647. PubMed ID: 22837718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.
    Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y
    Front Immunol; 2021; 12():607836. PubMed ID: 33717090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome.
    Lutskiy MI; Beardsley DS; Rosen FS; Remold-O'Donnell E
    Blood; 2005 Oct; 106(8):2815-7. PubMed ID: 15985539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction.
    Wada T; Jagadeesh GJ; Nelson DL; Candotti F
    Hum Gene Ther; 2002 Jun; 13(9):1039-46. PubMed ID: 12067437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Boztug K; Dewey RA; Klein C
    Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.